BCS-C01

N/A

Report date: 2025/01/26 16:36:11

Base Information

Drug NameBCS-C01
Drug Alias NameBCS-C01
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationInflammationAutoimmune Diseases +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesBCell Solutions Inc
Active IndicationsNerve DegenerationInflammationAutoimmune Diseases +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A